Receive Windhover's unique market insight fast with our free alert
service 'Windhover's Update', including the latest abstracts
and summaries from:
• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight
Sign up
now
|
|
 |
|
|
View more from the latest issues of:
|
|
|
|
|
 |
New ElsevierBI Search for ALL Pubs with Custom RSS NOW AVAILABLE!
The enhanced search enables you to search across all our publications and deals content in one search function. Interested in customizing your own RSS feeds? The new
RSS functionality allows you to access predefined RSS feeds via one simple click based on publication and topic as well as create new feeds based on your criteria so you can create alerts, or feed headlines onto a web site or intranet. Click on the
Advanced Search in the box above to begin your search or to subscribe any of our feeds now! |
|
|
|
Successfully Grow Your Medical Technology Business Through Financing, Acquisition, and Partnering
Join the Following Investors Who Share their Criteria on Where to Place their Device Bets:
Edmond de Rothschild Investment Partners - Boston Scientific - Sofinnova Partners - Abingworth LLP - Earlybird Venture Capital - NBGI Ventures - De Novo Ventures - Index Ventures - 360° Capital Partners - Ysios Capital
And many more! See the latest presenter list at www.IN3Europe.com
IN3 events bring together early/mid/late-stage, medical technology innovators with leaders in investment, venture capital, and business development – all in a single forum! Gain a keen understanding of the emerging technologies that are on track to make a distinct impact on the intensely-competitive and evidence-driven medical device industry.
|
|
Click here to learn more about
www.in3europe.com. |
 |
|
|
|
Euro-Biotech Forum website now active! Register by Feb. 14 to save $400.
Windhover Conferences will host its 17th Annual
Euro-Biotech Forum, the best global partnering meeting for American and European life science companies, with the highest concentration of senior level biopharma executives.
Euro-Biotech Forum features powerhouse plenary discussions with WIndhover’s expert editorial teams plus and one-on-one partnering meetings, all at the elegant Hilton Arc de Triomphe Paris.
Registration is now open, and attendees can save up to $400 by registering before Feb. 14.
|
|
For more information and to register, go to
www.eurobiotechforum.com. |
 |
|
|
|
Special Report: Oncology Outlook: How Cutting-Edge Medical Technology is Improving the Odds for Cancer Patients
With a huge and still growing population
vulnerable to breast, prostate and colon cancer, screening and treatment
represent an almost unlimited market. But some devices and diagnostics are the
wave of the future — including digital tomosynthesis imaging, partial breast
irradiation, virtual colonoscopy and HIFU (high-intensity focused ultrasound)
prostate treatment — while others are starting to suffer from their own
individual drawbacks. Where should you jump into the market? Who's already
there, and who's challenging the major players?
This Special Report answers all these questions and more with in-depth analysis of the potential market for everything from traditional radiation oncology to the leading-edge robotic radical prostatectomy diagnosis and treatment modalities.
Click here for more information
and to order. |
|
 |
|
|
|
Will you be the next envied start-up that was funded or acquired thanks to an IN3 event? Will you be the next savvy investor in on a hot new innovation thanks to an IN3 event?
|
Elsevier is proud to announce IN3 West! Coming to Las Vegas in March! IN3 events bring together early/mid/late-stage, medical technology innovators with leaders in investment, venture capital, and business development – all in a single forum! Gain a keen understanding of the emerging technologies that are on track to make a distinct impact on the intensely-competitive and evidence-driven medical device industry. Elsevier is proud to say that many young companies have worked their way up the funding ladder and into the marketplace via the relationships they formed at IN3 events.
|
|
Click here to learn more about the next IN3 event! |
 |
|
|
|
One hotel. One city. One trip. TWO Premium conferences.
NEW THIS YEAR! Perfect your dealmaking skills and find the perfect partners, all at the same time!
The Biotechnology Industry Organization (BIO) and Windhover Conferences are proud to host the combined
BIO-Windhover AND Pharmaceutical Strategic Outlook together! For the first time ever, ALL partnering, plenary sessions and networking events are open to attendees of both conferences. One city, one trip, TWO blockbuster conferences!
|
|
|
For more information and to register, please go to www.biowindhoverpso.com the combined BIO-Windhover/Pharmaceutical Strategic Outlook partnering site. |
 |
|
|
|
Upcoming Windhover & IN3 Webinars
Windhover & IN3 Webinars have served more than 3,000 participants with insightful, thought-provoking and action-oriented discussions of our industry — straight from the minds of those in the know.
To learn more about Windhover Webinars and to register
click here.
|
|
|
| | | |
|
|
 |
|
|
|
 |
|
 |
|
|
| |
 |
Biopharma Trends: Nowhere To Go But Up
Biopharmaceutical trends in 2008 were fundamentally altered by the global financial crisis. And 2009's events were similarly impacted by the ongoing recovery. . . [MORE] (IN VIVO)
The A-List: 2009's Trend-Shaping Series A Financings
New company creation slipped significantly in 2009 as venture capitalists conserved capital and supported existing portfolio companies. . . [MORE] (Start-Up)
Stent Market Doldrums Push Interest Elsewhere
The new realities of the drug-eluting stent market are evident in recent sales results from the big competitors, driving many of them to branch into other higher growth areas. . . [MORE] (Medtech Insight)
The Future of Pharma: The Scale to Fail
The pharmaceutical sector saw a wave of major consolidation in 2009. There are a number of lessons to be learned from the M&A activity that can be applied to the New Year, including the increasing need to get bigger in order to absorb the R&D misses. . . [MORE] (The RPM Report)
Read
more from the latest:
IN VIVO,
Start-Up,
The RPM Report,
Medtech Insight, "The Pink Sheet",
"The Pink Sheet" DAILY,
"The Rose Sheet",
"The Tan Sheet",
PharmAsia News,
Pharmaceutical Approvals Monthly, and
"The Gray Sheet".
|
|
|
|
| |
|
|
|
|
|
